Sort
53,477 grants matching “addiction”
Etiology of Sexual Risk, Substance Abuse, & Trauma; A Bioecological Systems Model
$601,811Laura L Otto-Salaj · University Of Wisconsin Milwaukee · R01 · FY2011 · DA
A Prospective Study of the Nonmedical use of Prescription Medications by Adolesce
$601,798Carol J Boyd · University Of Michigan At Ann Arbor · R01 · FY2012 · DA
Fostering Mothers Emotionally-Responsive Parenting
$601,776Nancy E Suchman · Yale University · R01 · FY2016 · DA
Genome-Wide Associations Environmental Interactions in the Lung Health Study
$601,774Kathleen C Barnes · Johns Hopkins University · U01 · FY2009 · HG
Prevention and Methodology Training
$601,729Jennifer L Maggs · Pennsylvania State University, The · T32 · FY2022 · DA
Novel Probes For Monoamine Transporters
$601,665Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2013 · DA
Project POINT: Effectiveness and Scalability of an Overdose Survivor Intervention
$601,645Alan Benjamin McGuire · Indiana University Indianapolis · R33 · FY2019 · DA
Dual Processes in HIV Risk Behavior in Drug Abusers
$601,640Alan W Stacy · Claremont Graduate University · R01 · FY2011 · DA
Developing and Testing a Computer-Based Alcohol Use Disorder Recovery System
$601,628David H Gustafson · University Of Wisconsin-Madison · R01 · FY2008 · AA
Molecular and Cellular Profiling of the Habenulointerpeduncular Circuit in Opioid Tolerance and Withdrawal
$601,612Jessica Ables · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DA
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
$601,611Robert A Schnoll · University Of Pennsylvania · R01 · FY2012 · DA
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
$601,606Jack Bergman · Mclean Hospital · R01 · FY2019 · DA
Impact of Reduced Cannabis Use on Functional Outcomes
$601,588Nathan A. Kimbrel · Duke University · R33 · FY2023 · DA
Characterizing brain dynamic biomarkers of fentanyl using intracranial and high-density electroencephalogram in humans
$601,503Patrick L. Purdon · Stanford University · R01 · FY2025 · DA
Probing RAS-mediated Signaling with Monobody Inhibitors
$601,496John P O'Bryan · Medical University Of South Carolina · R01 · FY2022 · CA
3/11 Epigenetic Regulation of Neuroimmune Pathways
$601,471Sean P Farris · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · AA
Enhanced Smoking Cessation for University Students
$601,467Alexander V Prokhorov · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Brain reward responses to sweet tastes in alcoholism risk
$601,406David A Kareken · Indiana University Indianapolis · R01 · FY2014 · AA
Development of Dual Dopamine/Serotonin Releasing Agents
$601,275Richard Rothman · National Institute On Drug Abuse · ZIA · FY2009 · DA
mGluR5 Allosteric Modulators
$601,275Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2009 · DA
Evaluating Alternative Aftercare Models for Ex-Offenders
$601,234Leonard A Jason · De Paul University · R01 · FY2011 · DA
Enhancing Follow-up Rates through a Rechargable Incentive Card (RIC) System
$601,226David J Farabee · Calance Corporation · R42 · FY2012 · DA
Chemistry and Biology of Mitragynine Alkaloids
$601,224Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2021 · DA
Pharmacological Treatment of Cannabis Withdrawal and Dependence
$601,174Barbara J Mason · Scripps Research Institute, The · R01 · FY2011 · DA
Neural Substrates of Cigarette Craving, Withdrawal, and Relief: Male-Female Differences
$601,159Edythe D London · University Of California Los Angeles · R37 · FY2022 · DA